Shingrix is an intramuscular (IM) injection, not subcutaneous (SQ). Both the CDC and FDA specify that Shingrix must be given as an IM injection into the deltoid muscle of the upper arm.
Why Intramuscular and Not Subcutaneous
Shingrix contains a powerful immune-boosting component (an adjuvant) that works best when delivered into muscle tissue. Muscle has a rich blood supply and contains immune cells that help generate a strong, lasting response to the vaccine. Subcutaneous tissue, the fatty layer just under the skin, doesn’t produce the same level of immune activation. Giving Shingrix into fat instead of muscle could reduce how well the vaccine works and may increase the chance of irritation at the injection site.
Where the Shot Goes
The preferred injection site is the deltoid, the thick muscle at the top of your upper arm. This is the same spot used for most adult vaccines, including flu shots and COVID boosters. The needle goes straight into the muscle at a 90-degree angle rather than at the shallow angle used for subcutaneous injections.
The CDC recommends a 22- to 25-gauge needle, with the length chosen based on body weight:
- 130 lbs or less: 1-inch needle
- 130 to 152 lbs: 1-inch needle
- Men 153 to 260 lbs, women 153 to 200 lbs: 1- to 1.5-inch needle
- Men over 260 lbs, women over 200 lbs: 1.5-inch needle
A longer needle ensures the vaccine actually reaches muscle and doesn’t end up in the subcutaneous layer. For very lean adults under 130 lbs, some experts say a 5/8-inch needle can work as long as the skin is stretched tightly and the underlying tissue isn’t bunched up.
What If It’s Given Subcutaneously by Mistake
Accidental subcutaneous administration does happen occasionally with IM vaccines. General CDC guidance for vaccines labeled IM-only is that a dose given subcutaneously by mistake does not typically need to be repeated. However, the injection site may be more sore or swollen than usual. If you’re concerned a dose was given incorrectly, your pharmacist or doctor can advise whether the dose should count toward your series.
The Two-Dose Schedule
Shingrix requires two IM doses to complete the series. The CDC recommends the second dose 2 to 6 months after the first for most adults 50 and older. If you have a weakened immune system or are about to start immunosuppressive treatment, the second dose can be moved up to as early as 1 to 2 months after the first so you finish the series sooner.
Both doses go into the deltoid. They don’t need to be in the same arm, so if one side is still sore from the first shot, you can ask for the second in the opposite arm.
What the Injection Feels Like
Shingrix has a reputation for causing noticeable soreness at the injection site. Because the vaccine is delivered into muscle along with its adjuvant, your arm may feel tender, swollen, or warm for a day or two. Many people also experience fatigue, muscle aches, or a mild headache after either dose. These side effects are signs of a strong immune response and typically clear up within 2 to 3 days. The second dose tends to cause more noticeable reactions than the first.

